Cipla may be privately owned, but effectively it has been a ‘national asset — with each brick representing Indian ingenuity, enterprise, and strength of character. While shareholders will most likely have no reason to complain, the end losers of Ciplas founding familys potential exit will be millions of underprivileged patients in India and the developing world.